GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Together Pharma TGTR.TA · ILA

Communication Services · Tel Aviv · 🇮🇱 Israel

Compare

183.20

+1.16%

Close of 9 Nov 2026, in ILA

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in ILS, from our data supplier.

FY2024

Revenue

ILS 96.1m

FY2015FY2024

Net income

−ILS 1.2m

FY2015FY2024

Free cash flow

ILS 1.4m

FY2015FY2024

Shareholders' equity

ILS 33.3m

FY2015FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
RevenueILS 96.1mILS 91.0mILS 31.2mILS 12.0mILS 11.2m————ILS 10.5m
Research and development————————ILS 24,000ILS 982,300
Operating incomeILS 11.3mILS 15.4mILS 1.9m−ILS 5.5m−ILS 7.8m−ILS 17.7m−ILS 152.1m−ILS 2.2m−ILS 2.9m−ILS 884,700
Net income−ILS 1.2m−ILS 4.3m−ILS 33.5m−ILS 13.8mILS 7.2m−ILS 15.3m−ILS 149.9m−ILS 5.5m−ILS 3.5m−ILS 1.3m
Diluted earnings per share-0.09-0.49-4.15-2.051.24-0.30-3.60-0.70-0.58-0.29

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Total assetsILS 147.1mILS 138.5mILS 129.8mILS 158.6mILS 125.2mILS 67.9mILS 20.6mILS 1.6mILS 7.7mILS 13.1m
Cash and short-term investmentsILS 8.4mILS 3.6mILS 5.3mILS 5.1mILS 5.8mILS 1.1mILS 235,000ILS 1.5mILS 126,600ILS 2.8m
Total liabilitiesILS 113.7mILS 146.3mILS 130.2mILS 138.0mILS 116.9mILS 78.7mILS 50.3mILS 1.7mILS 6.4mILS 9.1m
DebtILS 63.7mILS 97.7mILS 94.9mILS 67.6mILS 88.9mILS 50.2mILS 44.5mILS 746,000ILS 5.2mILS 5.4m
Shareholders' equityILS 33.3m−ILS 7.8m−ILS 426,000ILS 20.6mILS 8.3m−ILS 10.9m−ILS 29.8m−ILS 174,500ILS 1.3mILS 4.0m
Shares outstanding12m9m8m7m6m50m42m8m6m5m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operationsILS 2.8mILS 14.8m−ILS 13.7m−ILS 18.6m−ILS 9.7m−ILS 6.8m−ILS 5.4m−ILS 2.2m−ILS 3.0m−ILS 3.6m
Capital spending−ILS 1.5m−ILS 866,000−ILS 333,000−ILS 1.5m−ILS 13.8m−ILS 12.1m−ILS 3.9m−ILS 3,400−ILS 17,100−ILS 615,600
Free cash flowILS 1.4mILS 14.0m−ILS 14.1m−ILS 20.2m−ILS 23.5m−ILS 18.9m−ILS 9.3m−ILS 2.2m−ILS 3.1m−ILS 4.2m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021
RevenueILS 63.6mILS 45.7mILS 50.4mILS 45.5mILS 45.5mILS 21.4mILS 9.8mILS 2.2m
Operating incomeILS 8.5m−ILS 547,000ILS 11.9mILS 5.0mILS 10.4m−ILS 1.5m−ILS 4.8m−ILS 6.9m
Net incomeILS 974,000−ILS 7.5mILS 6.4m−ILS 8.9mILS 4.6m−ILS 19.0m−ILS 14.6m−ILS 4.7m
Diluted earnings per share0.07-0.550.50-1.020.52-2.19-1.94-0.64
Total assetsILS 151.6mILS 147.1mILS 154.3mILS 138.5mILS 133.3mILS 129.8mILS 131.1mILS 158.6m
Cash and short-term investmentsILS 9.6mILS 8.4mILS 7.6mILS 3.6mILS 3.3mILS 5.3mILS 12.2mILS 5.1m
DebtILS 14.3mILS 20.7mILS 23.7mILS 79.2mILS 83.6mILS 87.4mILS 74.6mILS 66.7m
Shareholders' equityILS 46.8mILS 33.3mILS 41.0m−ILS 7.8mILS 1.3m−ILS 426,000ILS 14.1mILS 20.6m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue99.9%—30.3%
Net income-56.0%-40.2%-13.3%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin14.3%10.0%——
Net margin-2.9%-22.9%——

Valuation history

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Price to earnings-40.8-7.9-0.6-5.119.7-105.8-14.0-19.8-12.6-64.5
Price to sales0.50.40.65.912.5————8.1

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 29 Mar 2011.

FY2011
Paid in the year2.891
  • 10-to-1 reverse split · 13 Aug 2023
  • 10-to-1 reverse split · 28 Aug 2016
  • 10-to-1 reverse split · 15 Jul 2012

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.